Results 141 to 150 of about 39,275 (210)

Various GLP-1 Receptor Agonist Preference Use with a Special Focus on Oral and Subcutaneous Forms in Poland. [PDF]

Healthcare (Basel)
Nowak K, Dziewierz A, Sojda A, Zabojszcz M, Szarpak Ł, Dardzinska N, Jaskulska P, Siudak Z.   +7 more
europepmc   +1 more source

Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia. [PDF]

Skin Appendage Disord
Alharbi S, Alkhalifah A.
europepmc   +1 more source

Nonsurgical Aesthetic Treatment of the Face and Neck in GLP-1 Receptor Agonist Weight Loss Patients: Experience-Based Considerations. [PDF]

Aesthet Surg J Open Forum
Moradi A, Denkova R, Holcomb K, Rossi A, Ashourian N.   +4 more
europepmc   +1 more source

Real-World Use of GLP-1 Receptor Agonist Liraglutide in Adolescents with Obesity: A First Longitudinal Single-Center Analysis from Switzerland. [PDF]

Children (Basel)
Noordam C, Eiholzer U, Katschnig C, Stasinaki A, Dubinski I.   +4 more
europepmc   +1 more source

Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes. [PDF]

Diabetes Care
Graham TE, Raghinaru D, Afreen S, Ahmann A, Haidar A, Raskin P, Tsoukas MA, Lum JW, Sasson-Katchalski R, Pinsker JE, Beck RW, 2IQP Study Group* .   +11 more
europepmc   +1 more source

<i>In silico</i> investigations of albumin-GLP-1 receptor agonist complexes for diabetes drug delivery applications. [PDF]

Comput Struct Biotechnol J
Murphy G, Cheung D, Fitzgerald M, Pandit A.   +3 more
europepmc   +1 more source

Kappa Counterconditioning of Cocaine Cues [PDF]

, 2018
Mantsch, John R., Twining, Robert C.
core   +1 more source

Clinical Efficacy of a Flavo-Proxylane Topical Regimen Pre- and Post-ultrasound Procedure for Subjects Undergoing Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy. [PDF]

Dermatol Ther (Heidelb)
Moradi A, Kim JH, Kim JM, Choudhary HN, Brieva PM.   +4 more
europepmc   +1 more source